About Aromasin 25 mg Tablet
Aromasin 25 mg Tablet is used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Aromasin 25 mg Tablet contains Exemestane, which works by blocking the aromatase enzyme, which produces the estrogen hormone. Thus, it lowers the amount of estrogen (the natural female hormone) produced in the body.
In some cases, you may experience common side effects such as difficulty sleeping, nausea, headache, musculoskeletal pain, increased sweating, and fatigue. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Aromasin 25 mg Tablet should not be taken in conditions like liver and kidney disease. Talk to your doctor before taking Aromasin 25 mg Tablet if you have any type of allergy with Aromasin 25 mg Tablet or any part of Aromasin 25 mg Tablet . Aromasin 25 mg Tablet should not be taken if you are pregnant or planning to become pregnant or breastfeeding. Aromasin 25 mg Tablet should not be given to children as safety has not been established.
Uses of Aromasin 25 mg Tablet
Aromasin 25 mg Tablet is used in the treatment of breast cancer in women. The detailed uses of Aromasin 25 mg Tablet are as follows:
- Treats Breast Cancer in Postmenopausal Women: Aromasin 25 mg Tablet is used to treat early-stage, hormone receptor-positive breast cancer in women after menopause (cessation of periods) by reducing estrogen levels, which drives the growth of cancer cells.
- Maintenance Therapy to Prevent Cancer Recurrence: Aromasin 25 mg Tablet is often prescribed after 2-3 years of tamoxifen therapy (hormone treatment) to reduce the risk of breast cancer recurrence by further suppressing estrogen production.
- Treats Advanced or Metastatic Breast Cancer: Aromasin 25 mg Tablet is also used to treat advanced hormone receptor-positive breast cancer in postmenopausal women when other hormonal therapies have not been effective.
